PRA operates GLP-compliant and harmonized bioanalytical laboratories in the United States (Lenexa, Kansas) and Europe (Assen, The Netherlands). Both laboratories are co-located with PRA’s Phase I clinics to enable close collaboration and rapid turn-around for time-critical studies which enables faster drug development decision making - a critical requirement for today’s adaptive trials.